44 results on '"Houhou-Fidouh, Nadhira"'
Search Results
2. Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child
3. Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study
4. CT features of community-acquired pneumonia at the emergency department
5. Rhinoviruses: molecular diversity and clinical characteristics
6. Human inherited complete STAT2 deficiency underlies inflammatory viral diseases
7. Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients
8. Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel
9. Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements
10. Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection
11. Clinical and virological data of the first cases of COVID-19 in Europe: a case series
12. HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients
13. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients
14. Genomic diversity of mpox virus in Paris area (France) during the 2022 outbreak
15. Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study
16. Breakthrough infections after post-exposure vaccination against Monkeypox
17. Severely impaired humoral response against SARS-CoV-2 variants of concern following two doses of BNT162b2 vaccine in patients with systemic lupus erythematosus (SLE)
18. Preliminary results on transmission of SARS‐CoV ‐2 antibodies to the fetus and serum neutralizing activity
19. Alpha (B.1.1.7) and Delta (B.1.617.2 – AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage
20. Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants
21. Corrigendum to ‘detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives’
22. Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient
23. The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
24. Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis
25. The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
26. Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
27. Viral epidemiology and SARS‐CoV‐2 co‐infections with other respiratory viruses during the first COVID‐19 wave in Paris, France
28. Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments
29. Case reports study of the first five patients COVID-19 treated with remdesivir in France
30. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients
31. Case report study of the first five COVID-19 patients treated with remdesivir in France
32. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection
33. Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients
34. SARS-CoV-2 specific antibody responses in COVID-19 patients
35. Was Zika introduced to Brazil by participants at the 2013 Beach Soccer World Cup held in Tahiti: A phylogeographical analysis
36. Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
37. Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016
38. Usefulness of multiplex PCR methods and respiratory viruses’ distribution in children below 15 years old according to age, seasons and clinical units in France: A 3 years retrospective study
39. Zika virus in the female genital tract
40. Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia
41. MPOX VIRUS SEQUENCES DIVERSITY IN PARIS AREA DURING THE 2022 OUTBREAK.
42. Additional file 1 of HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients
43. Additional file 1 of HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients
44. Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.